Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Andrew Leech

Dr Andrew Leech

Managing Paediatric Anxiety in General Practice

Prof Brendon Yee

Prof Brendon Yee

OSA – Which Test for Which Patient

Dr Sonia Davison

Dr Sonia Davison

Musculoskeletal Health in Menopause

Mr David Gardner

Mr David Gardner

AHPRA-Proof Your Practice – Social Media Risks for GPs

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024